Do you think it’s too late to buy Tempus AI share? The biggest reason here is why there is still time.

Refuse to slow down since the beginning of the new year, shares of Tempus AI (Nasdaq: Tem) Almost 99% have shot down since January 1. In view of the strong performance of artificial intelligence (AI) this year, potential investors could fear that the growth potential of the share price for tempus remains, an innovator when using AI solutions to the health industry.

However, this Bärische conclusion cannot properly recognize that there is a lot of fuel left in the tank, which could help to advance the temporary stock even higher in the coming months and years.

While the rise of Tempus AI is impressive, it is great to come to the conclusion that the potential for further growth has evaporated. The company recently completed the acquisition of Ambry Genetics and Tempus Ai with the possibility of offering patients more comprehensive cancer screening with the hereditary cancer assay from Ambry. In addition, Tempus Ai now has the option of expanding to other health areas after the acquisition of Amby, including pediatrics, reproductive health and immunology.

It is still the early innovations for Tempus AI, and the company is already recognized for its demanding AI offers. In 2023, for example, the company reported 125% net sales binding and illustrated how customers were motivated to deepen their relationships with Tempus AI – a clearly promising sign.

Management projects 2024 income – lack of the contribution of Ambry – of 700 million US dollars and adjusted results before interest, taxes, depreciation and amortization (EBITDA) of negative $ 105 million, including the contribution of sales from the amby. If the company reaches these forecasts, sales growth of 32% compared to the previous year and an EBITDA improvement of over $ 50 million will be represented compared to 2023.

There is still enough time for growth investors to click on the “Buy” button on Tempus AI share. However, it is important that the road that lies ahead of us can be rocky. Therefore, only those who feel comfortable with an investment with a higher risk improvement should take into account positions at this time.

Before you buy stocks in Tempus AI, you should consider the following:

The Motley Fool Stock Advisor The team of analysts just identified what they think they are 10 Best stocks So that investors can buy now … and Tempus AI was not one of them. The 10 shares that made the cut were able to achieve Monster Returns in the coming years.

The story continues